Companies /Healthcare

Vertex Pharmaceuticals Inc

NASDAQ: VRTX Biotechnology
$547.55
â–² $0.26 (+0.05%) today
Markets closed · 7:32pm ET

VRTX Coverage

Page 17
10:07am ET
Health and Healthcare

Biotech Business Daily (BIIB, VRTX, ALNY, STEM)

Here are some of the top stories affecting key drug and biotech stocks this Friday.  We also have links through to more detailed coverage and analysis at BioHealthInvestor.com: Biogen Idec Inc. (Nasdaq:…

Douglas A. McIntyre
11:23am ET
Health and Healthcare

Biotech Busine$$ Daily (BNT, TEVA, BPAX, NCST, RPRX, VRTX)

Bentley Pharmaceuticals Inc. (NYSE: BNT) will be purchased by Teva Pharmaceutical Industries (NASDAQ: TEVA) for $360 million. Bentley shareholders will receive $15 per share and an undisclosed amount of shares in CPEX…

Douglas A. McIntyre
4:56pm ET
Investing

The 52-Week Low Club (VRTX)(NT)(DY)

Dycom Industries (DY) Company lowers forecast. Falls to $15 from 52-week high of $34.13. Nortel Networks (NT) Sel-off at the end of the day. No news. Falls to $10.28 from 2-week high…

Douglas A. McIntyre
4:02pm ET
Investing

The 52-Week Low Club (ARUN)(UBS)(IAR)

Idearc (NYSE: IAR) Sell off from bad earnings continues. Falls to $8.55 from 52-week high of $38. R H Donnelley (NYSE: RHD) Shares downgraded. Sells off to $17.33 from 52-week high of…

Douglas A. McIntyre
7:58am ET
Investing

Pre-Market Stock News (January 23, 2008)

We are full fledged into earnings season now, so most news coverage will point to the current earnings environment and guidance.  There are of course drug developments and other contracts awards.  Below…

Douglas A. McIntyre